https://www.selleckchem.com/pr....oducts/wortmannin.ht
71months. Median time to VTE from diagnosis was 2.6months for IDH mutated astrocytomas compared to 3.06months for the IDH wild type astrocytomas (p=0.8663). IDH gene status did not appear as a significant risk factor for the development of venous thromboembolism (VTE) in our cohort of astrocytoma patients. Further research into potential biomarkers for VTE may be warranted. IDH gene status did not appear as a significant risk factor for the development of venous thromboembolism (VTE) in our cohort of astrocytoma patients. Further res